The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Abstract
The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, addictive substances lead to further blunting of the reward response,180 particularly in the VS.”
From Early life adversity and health-risk behaviors: Proposed psychological and neural mechanisms (2018) · cites this paper as [180]
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Self-citationGetting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
The Orbitofrontal Cortex and Reward
Rolls, E. T. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.284 · Cited by 1,595
Limbic Activation During Cue-Induced Cocaine Craving
Childress, A. R., Mozley, P. D., McElgin, W., Fitzgerald, J., Reivich, M., & O’Brien, C. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.11 · Cited by 1,513
Relative reward preference in primate orbitofrontal cortex
Tremblay, L., & Schultz, W. (1999) · Nature · doi:10.1038/19525 · Cited by 1,314
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
Self-citationAssociation of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Self-citationReward processing in primate orbitofrontal cortex and basal ganglia
Schultz, W. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.272 · Cited by 942
Activation of memory circuits during cue-elicited cocaine craving.
Grant, S., London, E. D., Newlin, D. B., Villemagne, V. L., Liu, X., Contoreggi, C., Phillips, R. L., Kimes, A. S., & Margolin, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.12040 · Cited by 936
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli
Garavan, H., Pankiewicz, J., Bloom, A., Cho, J.-K., Sperry, L., Ross, T. J., Salmeron, B. J., Risinger, R., Kelley, D., & Stein, E. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1789 · Cited by 931
Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924
Self-citationThe addicted human brain: insights from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18533 · Cited by 916
Self-citationVolkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Self-citationWise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Self-citationRELATION BETWEEN PHYSIOLOGICAL FUNCTION AND ENERGY METABOLISM IN THE CENTRAL NERVOUS SYSTEM
Sokoloff, L. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb03919.x · Cited by 807
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Self-citationElectrophysiological correlates for response inhibition in a Go/NoGo task
Bokura, H., Yamaguchi, S., & Kobayashi, S. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00691-5 · Cited by 769
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Self-citationOral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 1×
“19 Intravenous amphetamine also increases DA in human brain and these increases have also been shown to be associated with the subjective perception of reinforcement”
BackgroundSocial dominance in monkeys: dopamine D2 receptors and cocaine self-administration
Morgan, D., Grant, K. A., Gage, H. D., Mach, R. H., Kaplan, J. R., Prioleau, O., Nader, S. H., Buchheimer, N., Ehrenkaufer, R. L., & Nader, M. A. (2002) · Nature Neuroscience · doi:10.1038/nn798 · Cited by 674
Relationship between subjective effects of cocaine and dopamine transporter occupancy
Volkow, N. D., Wang, G., Fischman, M. W., Foltin, R. W., Fowler, J. S., Abumrad, N. N., Vitkun, S. A., Logan, J., Gatley, S. J., Pappas, N. R., et al. (1997) · Nature · doi:10.1038/386827a0 · Cited by 657
Self-citationMcCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
Franklin, T. R., Acton, P. D., Maldjian, J. A., Gray, J. D., Croft, J. R., Dackis, C. A., O’Brien, C. P., & Childress, A. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01269-0 · Cited by 599
Volkow, N. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180042006 · Cited by 575
Self-citationGlutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 553
Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards
Peciña, S., Cagniard, B., Berridge, K. C., Aldridge, J. W., & Zhuang, X. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09395.2003 · Cited by 551
de Wit, H., & Wise, R. A. (1977) · Canadian Journal of Psychology / Revue canadienne de psychologie · doi:10.1037/h0081662 · Cited by 491
Toward a Neuroanatomy of Obsessive-Compulsive Disorder
Insel, T. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090067011 · Cited by 458
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452
Self-citationChanges in brain glucose metabolism in cocaine dependence and withdrawal
Volkow, N. D., Fowler, J. S., Wolf, A. P., Hitzemann, R., Dewey, S. L., Bendriem, B., Alpert, R., & Hoff, A. L. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.621 · Cited by 451
Self-citationAddictive drugs as reinforcers: multiple partial actions on memory systems
WHITE, N. M. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb03586.x · Cited by 439
Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
Maldonado, R. J., Saiardi, A., Valverde, O., Samad, T. A., Roques, B. P., & Borrelli, E. (1997) · Nature · doi:10.1038/41567 · Cited by 436
Grace, A. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.1.x · Cited by 433 · cited 1×
“The dependency of the reinforcing effects of drugs on brain pharmacokinetic properties suggests a possible association with phasic DA cell firing (fast-burst firing at frequencies 30 Hz), which also leads to fast changes in DA concentration and whose function is to highlight the saliency of stimuli.(6) This is in cont…”
BackgroundA cannabinoid mechanism in relapse to cocaine seeking
Vries, T. J. D., Shaham, Y., Homberg, J. R., Crombag, H. S., Schuurman, K. G., Dieben, J., Vanderschuren, L. J. M. J., & Schoffelmeer, A. N. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1151 · Cited by 433
Gurevich, E. V. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 432
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., Hitzemann, R., & Pappas, N. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35115-8 · Cited by 422
Self-citationA computational substrate for incentive salience
McClure, S. M., Daw, N. D., & Montague, P. R. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00177-2 · Cited by 416
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 408
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Gifford, A., Hitzemann, R., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1440 · Cited by 406
Self-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., Hitzemann, R., Angrist, B., Gatley, S. J., Logan, J., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.19 · Cited by 405
Self-citationFraser, C., Power, M., Hamdy, S., Rothwell, J., Hobday, D., Hollander, I., Tyrell, P., Hobson, A., Williams, S. C. R., & Thompson, D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00705-5 · Cited by 401
Imaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Self-citationKreek, M. J., LaForge, K. S., & Butelman, E. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 371
Bassareo, V., De Luca, M. A., & Di Chiara, G. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04709.2002 · Cited by 339
Regional brain metabolic activation during craving elicited by recall of previous drug experiences
Wang, G.-J., Volkow, N. D., Fowler, J. S., Cervany, P., Hitzemann, R. J., Pappas, N. R., Wong, C. T., & Felder, C. (1999) · Life Sciences · doi:10.1016/s0024-3205(98)00619-5 · Cited by 336
Self-citationSPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333
Piazza, P. V., Rougé‐Pont, F., Deminière, J. M., Kharouby, M., Moal, M. L., & Simon, H. (1991) · Brain Research · doi:10.1016/0006-8993(91)91452-7 · Cited by 328
Overexpression of dopamine D2 receptors reduces alcohol self‐administration
Thanos, P. K., Volkow, N. D., Freimuth, P., Umegaki, H., Ikari, H., Roth, G., Ingram, D. K., & Hitzemann, R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00492.x · Cited by 324
Self-citationVolkow, N. D., Wang, G., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., Ding, Y., Gatley, S. J., Gifford, A., Zhu, W., et al. (2002) · Synapse · doi:10.1002/syn.10038 · Cited by 321
Self-citationComparison of acamprosate and placebo in long-term treatment of alcohol dependence
Whitworth, A. B., OBERBAUER, H., Fleischhacker, W. W., Lesch, O., Walter, H., Nimmerrichter, A., Platz, T., Fischer, F., & Potgieter, A. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91682-7 · Cited by 319
A pilot trial of topiramate for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Dackis, C. A., Sparkman, T., Weigley, C., & O’Brien, C. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.008 · Cited by 313
Human striatal response to salient nonrewarding stimuli
Zink, C. F., Pagnoni, G., Martin, M. E., Dhamala, M., & Berns, G. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-22-08092.2003 · Cited by 312
Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., Telang, F., Vaska, P., Ding, Y.-S., Wong, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11461.2003 · Cited by 302
Self-citationKujala, T., Karma, K., Čėponiené, R., Belitz, S., Turkkila, P., Tervaniemi, M. H., & Näätänen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181589198 · Cited by 291
FIXED‐INTERVAL SCHEDULE OF COCAINE REINFORCEMENT: EFFECT OF DOSE AND INFUSION DURATION1
Balster, R. L., & Schuster, C. R. (1973) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1973.20-119 · Cited by 290
Volkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1173 · Cited by 281
Self-citationBrain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study
Volkow, N. D., Wang, G., Fowler, J. S., Thanos, P., Logan, J., Gatley, S. J., Gifford, A. J., Ding, Y., Wong, C., & Pappas, N. R. (2002) · Synapse · doi:10.1002/syn.10137 · Cited by 278
Self-citationHemby, S. E., Co, C., Koves, T. R., Smith, J. E., & Dworkin, S. I. (1997) · Psychopharmacology · doi:10.1007/s002130050365 · Cited by 278
Utility of subjective-effects measurements in assessing abuse liability of drugs in humans.
Fischman, M., & Foltin, R. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01749.x · Cited by 266
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R., & Spealman, R. D. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20684-x · Cited by 244
Neural plasticity following auditory training in children with learning problems
Hayes, E. A., Warrier, C. M., Nicol, T. G., Zecker, S. G., & Kraus, N. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00414-5 · Cited by 237
Randomized Placebo-Controlled Trial of Baclofen for Cocaine Dependence
SHOPTAW, S. J., Yang, X., Rotheram-Fuller, E. J., Hsieh, Y.-C., Kintaudi, P. C., Charuvastra, V. C., & Ling, W. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1207 · Cited by 215
Papp, M., Klimek, V., & Willner, P. (1994) · Psychopharmacology · doi:10.1007/bf02245566 · Cited by 205
Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2003) · Synapse · doi:10.1002/syn.10238 · Cited by 200
Mechanism of New Antipsychotic Medications
Gründer, G., Carlsson, A., & Wong, D. F. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.974 · Cited by 199
A novel strategy for the treatment of cocaine addiction
Dewey, S. L., Morgan, A. E., Ashby, C. R., Horan, B., Kushner, S. A., Logan, J., Volkow, N. D., Fowler, J. S., Gardner, E. L., & Brodie, J. D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 194
Self-citationJulian, M. D., Martin, A. B., Cuéllar, B., de Fonseca, F. R., Navarro, M. A., Moratalla, R., & García‐Segura, L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00070-8 · Cited by 193
Replacement Medication for Cocaine Dependence
Grabowski, J. G., Roache, J. D., Schmitz, J. M., Rhoades, H. M., Creson, D. L., & Korszun, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00008 · Cited by 191
Naltrexone in the treatment of alcoholism: A clinical review
O’Brien, C. P., Volpicelli‐Daley, L. A., & Volpicelli, J. R. (1996) · Alcohol · doi:10.1016/0741-8329(95)02038-1 · Cited by 189
Volkow, N. D., Wang, G., Fowler, J. S., Fischman, M. W., Foltin, R. W., Abumrad, N. N., Gatley, S. J., Logan, J., Wong, C., Gifford, A. J., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00225-8 · Cited by 185
Self-citationCurrent pharmacological treatments for nicotine dependence
George, T. P., & O’Malley, S. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.003 · Cited by 179
Social and Emotional Self‐Regulation a
Tucker, D., Luu, P., & Pribram, K. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb38141.x · Cited by 174
Malison, R. T., Best, S. E., van Dyck, C. H., McCance, E. F., Wallace, E. A., Laruelle, M. A., Baldwin, R. M., Seibyl, J. P., Price, L. H., Kosten, T. R., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.832 · Cited by 156
Context-specific Enhancement of Glutamate Transmission by Cocaine
Bell, K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00100-7 · Cited by 152
Schlaepfer, T. E., Pearlson, G. D., Wong, D. F., Marenco, S., & Dannals, R. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1209 · Cited by 148
Ranaldi, R., Pocock, D., Zereik, R., & Wise, R. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04102.1999 · Cited by 148
Intravenous methylphenidate abuse. Prototype for prescription drug abuse
Parran, T. V. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.4.781 · Cited by 143
Pilot randomized double blind placebo‐controlled study of dexamphetamine for cocaine dependence
Shearer, J., WODAK, A. D., van Beek, I., Mattick, R. P., & Lewis, J. E. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00447.x · Cited by 142
Dopamine transporters increase in human brain after alcohol withdrawal
Laine, T., Ahonen, A. K., Torniainen, P., Heikkilä, J., Pyhtinen, J., Räsänen, P. K., Niemelä, O. J., & Hillbom, M. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000514 · Cited by 139
Behavioral and neural mechanisms of compulsive drug seeking
Vanderschuren, L. J. M. J., & Everitt, B. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.037 · Cited by 138
Kampman, K. M., Volpicelli, J. R., Mulvaney, F. D., Alterman, A. I., Cornish, J., Gariti, P., Cnaan, A., Poole, S. A., Muller, E., Acosta, T., et al. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00193-9 · Cited by 135
Immunotherapy for the treatment of drug abuse
Kosten, T., & Owens, S. M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.009 · Cited by 135
Lamensdorf, I., Youdim, M. B. H., & Finberg, J. P. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041532.x · Cited by 132
Reduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132
Gonzalez, G. M., Sevarino, K. A., Sofuoglu, M., Poling, J., Oliveto, A. H., Gonsai, K., George, T. P., & Kosten, T. R. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00544.x · Cited by 128
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Dewey, S. L., Hitzemann, R., Gifford, A. N., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37918-2 · Cited by 125
Self-citationKrantz, M. J., & Mehler, P. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.277 · Cited by 122
Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121
Dr. Volkow and Associates Reply
VOLKOW, N. D., HITZEMANN, R., FOWLER, J. S., & WOLF, A. P. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.12.1759-b · Cited by 117
Self-citationRisperidone for the Treatment of Cocaine Dependence: Randomized, Double-Blind Trial
Grabowski, J. G., Rhoades, H. M., Silverman, P. B., Schmitz, J. M., Stotts, A. L., Creson, D., & Bailey, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00003 · Cited by 116
Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse
Wallmichrath, I., & Szabó, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00109-4 · Cited by 110
Blockade of noradrenergic receptors in the basolateral amygdala impairs taste memory
Miranda, M. I., LaLumiere, R. T., Buen, T.-V., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.03008.x · Cited by 106
Isaac, W. L., Nonneman, A. J., Neisewander, J. L., Landers, T. M., & Bardo, M. T. (1989) · Behavioral Neuroscience · doi:10.1037/0735-7044.103.2.345 · Cited by 102
Intravenous Methylphenidate Abuse
Parran, T. V. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400040119027 · Cited by 101
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation
George, T. P., Vessicchio, J. C., Termine, A., Jatlow, P. I., Kosten, T. R., & O’Malley, S. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01454-3 · Cited by 100
The GABAB Receptor Agonist Baclofen Attenuates Cocaine- and Heroin-Seeking Behavior by Rats
Ciano, P. D., & Everitt, B. J. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300088 · Cited by 99
Changes in reward‐induced brain activation in opiate addicts
Martin-Söelch, C., Chevalley, A. ‐., Künig, G., Missimer, J. H., Magyar‐Lehmann, S., Mino, A., Schultz, W., & Leenders, K. L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01753.x · Cited by 96
Treating cocaine addiction: From preclinical to clinical trial experience with γ‐vinyl GABA
Brodie, J. D., Figueroa, E., & Dewey, S. L. (2003) · Synapse · doi:10.1002/syn.10278 · Cited by 96
Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence
LeDuc, P. A., & Mittleman, G. (1995) · Psychopharmacology · doi:10.1007/bf02246489 · Cited by 91
Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data
Brauer, L. H., Goudie, A. J., & de Wit, H. (1997) · Psychopharmacology · doi:10.1007/s002130050207 · Cited by 91
Effects of Expectancies on Subjective Responses to Oral Δ9-Tetrahydrocannabinol
Kirk, J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00414-0 · Cited by 87
Glutamatergic Agents for Cocaine Dependence
Dackis, C. A., & O’Brien, C. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.021 · Cited by 86
Mitchell, S. H., Jarzyna, C. L., & de Wit, H. (1996) · Psychopharmacology · doi:10.1007/bf02246020 · Cited by 85
Pharmacologic approaches to the management of alcoholism.
Anton, R. F. (2001) · PubMed · Cited by 79
Naltrexone administration affects ad libitum smoking behavior
Wewers, M. E., Dhatt, R., & Tejwani, G. A. (1998) · Psychopharmacology · doi:10.1007/s002130050756 · Cited by 76
The potential of dopamine agonists in drug addiction
George, T. P., Kosten, T. A., & Kosten, T. R. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.4.491 · Cited by 72
Moving around in a worm: netrin UNC-6 and circumferential axon guidance in C. elegans
Wadsworth, W. G. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02206-3 · Cited by 72
Svingos, A. L., Clarke, C. L., & Pickel, V. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1 · Cited by 67
Cocaine as a Risk Factor for Neuroleptic-Induced Acute Dystonia
van Harten, P. N., van Trier, J. C. A. M., Horwitz, E. H., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0307 · Cited by 67
Duvauchelle, C. L., Ikegami, A., Asami, S., Robens, J., Kressin, K., & Castañeda, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02091-6 · Cited by 63
Hotsenpiller, G., & Wolf, M. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00951-x · Cited by 63
Franklin, T. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00162-7 · Cited by 58
Papanicolaou, A. C., Simos, P. G., Breier, J. I., Fletcher, J. M., Foorman, B. R., Francis, D. J., Castillo, E. M., & Davis, R. N. (2003) · Developmental Neuropsychology · doi:10.1080/87565641.2003.9651912 · Cited by 51
Fenu, S., & Chiara, G. D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02899.x · Cited by 45
Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans
Evans, S. M., WALSH, S. L., LEVIN, F. R., Foltin, R. W., Fischman, M. W., & Bigelow, G. E. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00129-6 · Cited by 45
Bailey, D. J., Tetzlaff, J. E., Cook, J. M., He, X., & Helmstetter, F. J. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4050 · Cited by 38
Genetics of alcohol and other abused drugs
Crabbe, J. C., & Phillips, T. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00066-0 · Cited by 33
Gatley, S. J., Volkow, N. D., Gifford, A. N., Ding, Y., Logan, J., & Wang, G. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00655-7 · Cited by 33
Self-citationDopamine release during cocaine self-administration in rats: effect of SCH23390
Egilmez, Y., Jung, M. E., Lane, J. D., & Emmett‐Oglesby, M. W. (1995) · Brain Research · doi:10.1016/0006-8993(95)00987-5 · Cited by 25
Papanicolaou, A. C., Simos, P. G., Breier, J. I., Fletcher, J. M., Foorman, B. R., Francis, D. J., Castillo, E., & Davis, R. G. (2003) · Developmental Neuropsychology · doi:10.1207/s15326942dn242&3_05 · Cited by 23
Selegiline potentiates cocaine‐induced increases in rodent nucleus accumbens dopamine
Schiffer, W. K., Azmoodeh, M., Gerasimov, M. R., et al. (2003) · Synapse · doi:10.1002/syn.10183 · Cited by 20
Effects of cue exposure on brain glucose utilization 8 days after repeated cocaine administration
Knapp, C. M., Printseva, B., Cottam, N., & Kornetsky, C. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03011-1 · Cited by 17
Volkow (1999) · doi:10.1002/(sici)1098-2396(199901)31:1
Flagged first, then by citations
Research works printed but not linked: 2
- Graham J, Porrino LJ . Neuroanatomical substrates of cocaine self-administration. In: Hammer R (ed) Neurobiology of Cocaine. CRC Press: Boca Raton, FL, 1995 pp 3–14.
- De Wit H, Wise RA . Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 1977; 31: 195–203. · DOI · Paper page
Cited by
Sorted by citations
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationDysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Goldstein, R. Z., & Volkow, N. D. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3119 · Cited by 2,749
Self-citationThe Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Self-citationInhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
The incentive sensitization theory of addiction: some current issues
Robinson, T. E., & Berridge, K. C. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0093 · Cited by 1,717
Metadata
- Authors
- Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M.
- Affiliations
- National Institute on Drug Abuse (US)
- Brookhaven National Laboratory (US)
- University of California, Irvine (US)
- Corresponding author
- Volkow, N D
- Venue
- Molecular Psychiatry
- Published
- 2004-04-06
- Volume
- 9
- Issue
- 6
- Pages
- 557-569
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1980277133
- Cited by
- 1,101
- References
- 130
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 20 · 2023: 37 · 2022: 34 · 2021: 40 · 2020: 87 · 2019: 39 · 2018: 43 · 2017: 39 · 2016: 69 · 2015: 71 · 2014: 78 · 2013: 55 · 2012: 60
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of National Drug Control Policy
- National Institutes of Health (5r01da009490-08)
- National Institute on Alcohol Abuse and Alcoholism (AA-09481, R01AA009481)
- National Institute on Drug Abuse (DA-06891, DA-09490, DA-06278, R01DA006278, R01DA006891)
- Biological and Environmental Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- dopamine, drug addiction, drug reinforcement, motivation, salience, orbitofrontal cortex, cingulate gyrus, dopamine D2 receptor, striatum, impulsivity, inhibitory control, pharmacotherapy, behavior therapy
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Brain, Child, Dopamine, Humans, Neurons, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review